PUBLICATIONS

A complete list of publications by Dr. Bhat can be reviewed here.

Estrogen Receptor 1 Contributes to Sex-Specific Differences in Hepatocellular Carcinoma through Inhibition of Wnt signaling.

Bhat M, Pasini E, Pastrello C, Angeli M, Kotlyar M, Tokar T, Jurisica I. Frontiers in Oncology. Published November 2021

AASLD Hepatology Cover

Application of Machine Learning in Liver Transplantation.

Yang J, Sharma D, Bhat M.  Accepted, Hepatology International November 2021.

Sex Disparity in Liver Transplant and Access to Living Donation.

Karnam RS, Chen S, Xu W, Chen C, Elangainesan P, Ghanekar A, McGilvray I, Reichman T, Sayed B, Selzner M, Sapisochin G, Galvin Z, Hirschfield G, Asrani SK, Selzner N, Cattral M, Lilly L, Bhat M. JAMA Surg. Nov 2021.

Combined Proteomic/Transcriptomic signature of ALDH1A1, LGALS3, LGALS3BP is Associated with Recurrence Post-Liver Transplantation for Hepatocellular Carcinoma Beyond Milan. Clinical Proteomics.

Bhat M, Clotet-Freixas S, Baciu C, Pasini E, Hammad A, Ivanics T, Reid S, Azhie A, Angeli M, Ghanekar A, Fischer S, Sapisochin G, Konvalinka A. Nov 2021. 

Liver Retransplantation Using Living Donor Grafts: A Western Experience.

Patel MS, Ghanekar A, Sayed BA, Sapisochin G, McGilvray I, Raschzok N, Reichman T, Selzner M, Galvin Z, Bhat M, Stunguris J, Ng VL, Lilly L, Selzner N, Cattral M. Liver Transpl. Oct 2021.

Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long-Term Survival.

Azhie A, Sheth P, Hammad A, Woo M, Bhat M. Liver Transpl. Oct 2021.

Clinical Practice Guideline for Solid Organ Donation and Transplantation During the COVID-19 Pandemic.

Weiss MJ, Hornby L, Foroutan F, Belga S, Bernier S, Bhat M, Buchan CA, Gagnon M, Hardman G, Ibrahim M, Luo C, Luong ML, Mainra R, Manara AR, Sapir-Pichhadze R, Shalhoub S, Shaver T, Singh JM, Srinathan S, Thomas I, Wilson LC, Wilson TM, Wright A, Mah A. Transplant Direct. Sept 2021.

Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse.

Carrique L, Quance J, Tan A, Abbey S, Sales I, Lilly L, Bhat M, Galvin Z, Cattral M, Ghanekar A, McGilvray I, Reichman T, Sapisochin G, Sayed B, Selzner M, Lynch MJ, Selzner N. Gastroenterology. Aug 2021.

Early Allograft Dysfunction After Liver Transplantation With Donation After Circulatory Death and Brain Death Grafts: Does the Donor Type Matter?

Mazilescu LI, Kotha S, Ghanekar A, Lilly L, Reichman TW, Galvin Z, Cattral MS, Bhat M, McGilvray ID, Sapisochin G, Sayed B, Selzner M, Selzner N. Transplant Direct. July 2021.

Long-Term Outcomes of Pediatric Living versus Deceased Donor Liver Transplant Recipients: A Systematic Review and Meta-analysis.

Shingina A, Vutien P, Uleryk E, Shah PS, Renner E, Bhat M, Pai A, Tinmouth J, Kim J. Liver Transpl. July 2021.

Systematic review and meta-analysis of post-transplant diabetes mellitus in liver transplant recipients.

Lawendy B, Srinathan S, Kotha S, Gomes C, Misra S, Yu J, Orchanian-Cheff A, Tomlinson G, Bhat M. Clin Transplant. July 2021.

Transplantation Cover

Normothermic Ex Situ Liver Perfusion Enhances Mitochondrial Function of DCD Grafts as Evidenced by High-throughput Metabolomics.

Bhat M, Linares-Cervantes I, Pasini E, Patel P, Goto T, Noguchi Y, Mazilescu L, Urbanellis P, Selzner M, Selzner N. Transplantation. July 2021.

Single-Center North American Experience of Liver Transplantation in Autoimmune Hepatitis: Infrequent Indication but Good Outcomes for Patients.

de Quadros Onofrio F, Neong E, Adebayo D, Kollmann D, Adeyi OA, Fischer S, Hirschfield GM, Hansen BE, Bhat M, Galvin Z, Lilly LB, Selzner N. J Can Assoc Gastroenterol. July 2021.

The Lancet Digital Health cover

Effective Detection of Compensated Cirrhosis Using Machine Learning.

Sabet Sarvestany S, Kwong J, Cerocchi O, Ahmed Ali F, Karnam R, Kuriry H,Shengir M, Candido E, Duchen R, Patel K, Sebastiani G, Goldenberg A, Bhat M.  Lancet Digital Health. 2021 Jun 6.

The Impact of Primary Liver Disease and Social Determinants in a Mixed Donor Liver Transplant Program: A Single-Center Analysis.

Leung KK, Kim A, Hansen BE, Lilly L, Selzner N, Patel K, Bhat M, Hirschfield GM, Galvin Z. Prog Transplant. June 2021.

Idiopathic Fulminant Graft Failure Rescued by Urgent ABO-Incompatible Liver Transplantation. Prog Transplant.

Qazi-Arisar FA, Uchila R, Limkemann A, Galvin Z, Monajemzadeh M, Cattral M, Tinckam K, Sayad B, Bhat M. Prog Transplant. June 2021.

Long-term mortality risk stratification of liver transplant recipients: real-time application of deep learning algorithms on longitudinal data.

Nitski O, Azhie A, Qazi-Arisar FA, Wang X, Ma S, Lilly L, Watt KD, Levitsky J, Asrani SK, Lee DS, Rubin BB, Bhat M, Wang B. Lancet Digit Health. May 2021.

Faseb Journal Cover

The hippo pathway: A master regulator of liver metabolism, regeneration, and disease.

Nguyen-Lefebvre AT, Selzner N, Wrana JL, Bhat M. FASEB J. May 2021.

AASLD Hepatology Journal

Tacrolimus Impairs Kupffer Cell Capacity to Control Bacteremia: Why Transplant Recipients Are Susceptible to Infection.

Deppermann C, Peiseler M, Zindel J, Zbytnuik L, Lee WY, Pasini E, Baciu C, Matelski J, Lee Y, Kumar D, Humar A, Surewaard B, Kubes P, Bhat M. Hepatology. May 2021.

european respiratory journal

Transcriptomic investigation reveals donor-specific gene signatures in human lung transplants.

Baciu C, Sage A, Zamel R, Shin J, Bai XH, Hough O, Bhat M, Yeung JC, Cypel M, Keshavjee S, Liu M. Eur Respir J. April 2021.

REmote moBile Outpatient mOnitoring in Transplant (Reboot) 2.0: a randomized control trial protocol

Murray KR, Foroutan F, Amadio J, Posada JD, Kozuszko S, Duhamel J, Tsang K, Farkouh ME, McDonald M, Billia F, Barber E, Hershman SG, Bhat M, Tinckam KJ, Ross HJ, McIntosh C, Moayedi Y. JMIR Res Protoc. April 2021.

Long-term mortality risk stratification of liver transplant recipients: real-time application of deep learning algorithms on longitudinal data.

Osvald Nitski, Amirhossein Azhie, Fakhar Ali Qazi-Arisar, Xueqi Wang, Shihao Ma, Leslie Lilly, Kymberly D Watt, Josh Levitsky, Sumeet K Asrani, Douglas S Lee, Barry B Rubin, Mamatha Bhat*, Bo Wang*. Lancet Digit Health. April 2021.

ActiveDriverDB: Interpreting Genetic Variation in Human and Cancer Genomes Using Post-translational Modification Sites and Signaling Networks (2021 Update).

Krassowski M, Pellegrina D, Mee MW, Fradet-Turcotte A, Bhat M, Reimand J. Front Cell Dev Biol. 2021;9:626821. March 2021.

Integrative analysis of layers of data in hepatocellular carcinoma reveals pathway dependencies

Bhat M, Pasini E, Pastrello C, Rahmati S, Angeli M, Kotlyar M, Ghanekar A, Jurisica I.World J Hepatol. 2021;13(1):94-108.

Predicting Long-term Survival after liver transplantation in patients with NASH cirrhosis.

Karnam RS, Mitsakakis N, Saracino G, Lilly L, Asrani SK, Bhat M. Clin Gastroenterol Hepatol. doi.org/10.1016/j.cgh.2021.01.021. 2021 Jan 16:S1542-3565(21)00071-9.

Long- Term Risk Stratification of Liver Transplant Recipients: Real-time Application of Deep Learning Algorithms on Longitudinal Data.

Nitski O, Azhie A, Qazi-Arishar F A, Lilly L, Watt K, Levitsky J, Asrani S, Bhat M*, Wang B*. Lancet Digital Health. Accepted, Jan 2021.

Metabolic Consequences of Solid Organ Transplantation.

Bhat M, Usmani SE, Azhie A, Woo M. Endocrine Reviews. 2020 Nov 28. doi: 10.1210/endrev/bnaa030. Vol. XX, No. XX, 1-27.

Transcriptomic investigation reveals donor specific gene signatures in human lung transplants.

Baciu C, Sage A, Zamel R, Shin J, Bai XH, Hough O, Bhat M, Yeung JC, Cypel M, Keshavjee S, Liu M. Eur Respir J. DOI: 10.1183/13993003.00327-2020

Enteric dysbiosis in liver and kidney transplant recipients: a systematic review.

Sivaraj S, Chan A, Pasini E, Chen E, Lawendy B, Verna E, Watt E, Bhat M. Transplant International. 2020 Jul 8; Online(July 8th).

Renal dysfunction after liver transplantation: effect of donor type.

Kollmann, D., Neong, S.F., Rosales, R., Hansen, B.E., Sapisochin, G., McCluskey, S., Bhat, M., Cattral, M.S., Lilly, L., McGilvray, I.D., Ghanekar, A., Grant, D.R., Selzner, M., Wong, F.S. and Selzner, N. (2020). Liver Transpl. Accepted Author Manuscript. 2020 Mar 19.

Lipoprotein-like Nanoparticle carrying siRNA against SALL4 effectively targets Hepatocellular Carcinoma cells and decreases Tumor burden.

Cruz W, Huang H, Barber B, Pasini E, Zheng G, Chen J,  Bhat M. Hepatology Communications. 2020 Jan 10. In Press.

Applying Machine Learning in Liver Disease & Transplantation: A Comprehensive Review.

Spann A, Yasodhara A, Kang J, Watt K, Wang B, Goldenberg A, Bhat M. [published online ahead of print, 2020 Jan 6]. Hepatology. 2020;10.1002/hep.31103.

Diabetogenic Effects of Immunosuppression: An Integrative Analysis.

Bhat M, Pasini E, Das A, Baciu C, Angeli M, Humar A, Watt KD, Allard J. Transplantation. 2020 Jan 4;104(1).

The impact of preexisting and posttransplant diabetes mellitus after transplantation on outcomes after liver transplantation.

Aravinthan A, Doyle A, Galvin Z, Rajakumar R, Selzner N, Lilly L, Bhat M. Transplantation. 2019 Apr.

Live Donor Liver Transplantation for Patients with Hepatocellular Carcinoma Offers Increased Survival vs. Deceased Donation.

Goldaracena N, Gorgen A, Doyle A, Hansen BE, Tomiyama K, Zhang W, Ghanekar A, Lilly L, Cattral M, Galvin Z, Selzner M, Bhat M, Selzner N, McGilvray I, Greig PD, Grant DR, Sapisochin G. J Hepatol. 2019 Jan 7.

Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.

Galvin Z, Rajakumar R, Chen E, Adeyi O, Selzner M, Grant D, Sapisochin G, Greig P, Cattral M, McGilvray I, Ghanekar A, Selzner N, Lilly L, Patel K, Bhat M. Liver Transpl. 2019 Jan 1;25(1):56-67.

Living Donor Liver Transplantation Using Selected Grafts With 2 Bile Ducts Compared With 1 Bile Duct Does Not Impact Patient Outcome.

Kollmann D, Goldaracena N, Sapisochin G, Linares I, Selzner N, Hansen BE, Bhat M, Cattral MS, Greig PD, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M. Liver Transpl. 2018 Nov 1;24(11):1512-1522.

The Basis of Liver Regeneration: a Systems Biology approach.

Bhat M, Pasini E, Baciu C, Angeli M, Humar A, Macparland S, Feld J, McGilvray I. Annals of Hepatology. 2018 Oct.

Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.

Bhat M, Mara K, Dierkhising R, Watt K. Mayo Clinic Proceedings. 2018 Sep 4;93(9):1236-1246.

Splenectomy as Flow Modulation Strategy and Risk Factors of De Novo Portal Vein Thrombosis in Adult-to-Adult Living Donor Liver Transplantation.

Linares I, Goldaracena N, Rosales R, Maza L, Kaths M, Kollmann D, Echeverri J, Selzner N, McCluskey SA, Sapisochin G, Lilly LB, Greig P, Bhat M, Ghanekar A, Cattral M, McGilvray I, Grant D, Selzner M. Liver Transpl. 2018 Sep;24(9):1209-1220.

Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma.

Sadler EM, Mehta N, Bhat M, Ghanekar A, Greig PD, Grant DR, Yao F, Sapisochin G. Transplantation. 2018 Apr 10;102(4):640-647.

Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis

Bhat V, Srinathan S, Pasini E, Angeli M, Chen E, Baciu C, Bhat M. World Journal of Hepatology. 2018 Jan 27;10(1):155-165.

Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis.

Baciu C, Pasini E, Angeli M, Schwenger K, Afrin J, Humar A, Fischer S, Patel K, Allard J, Bhat M. PLoS One. 2017 Dec 7;12(12):e0189223.

Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study.

Aravinthan AD, Barbas AS, Doyle AC, Tazari M, Sapisochin G, Cattral MS, Ghanekar A, McGilvray ID, Selzner M, Greig PD, Bhat M, Selzner N, Grant DR, Lilly LB, Renner EL. Transplant International. 2017 Nov 30;30(11):1140-1149.

Effect of Immunosuppression on the Intestinal Microbiome: Implications for Post-transplant complications.

Bhat M, TPasini E, Copeland J, Renner E, Angeli M, Allard J, Guttman D, Humar A. Scientific Reports. 2017 Aug 31;7(1):10277.

Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma.

Aravinthan AD, Bruni SG, Doyle AC, Thein HH, Goldaracena N, Issachar A, Lilly LB, Selzner N, Bhat M, Sreeharsha B, Selzner M, Ghanekar A, Cattral MS, McGilvray ID, Greig PD, Renner EL, Grant DR, Sapisochin G. Ann Surg Oncol. 2017 Jul 3;24(7):1843-1851.

Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.

Kumar D, Patil N, Husain S, Chaparro C, Bhat M, Kim SJ, Humar A. Clinical Transplantation. 2017 Jul;31(7):e13000.

Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience.

Barbas AS, Goldaracena N, Dib MJ, Al-Adra DP, Aravinthan AD, Lilly LB, Renner EL, Selzner N, Bhat M, Cattral MS, Ghanekar A, McGilvray ID, Sapisochin G, Selzner M, Greig PD, Grant DR. Transplant Direct. 2017 May 10;3(6):e158.

Stereotactic body radiotherapy versus TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis.

Sapisochin G, Barry A, Doherty M, Fischer S, Goldaracena N, Rosales R, Russo M, Beecroft R, Ghanekar A, Bhat M, Brierley J, Greig PD, Knox JJ, Dawson LA, Grant DR. Journal of Hepatology. 2017 Feb 28;67(1):92-99.

Novel MELD Exception Point System for Hepatocellular Carcinoma based on Tumor Characteristics and Dynamics.

Bhat M, Ghali P, Dupont B, Hilzenrat R, Tazari M, Roy A, Chaudhury P, Alvarez F, Carrier M, Bilodeau M. Journal of Hepatology. 2017 Feb 6;66(2):374-381.

Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients.

Bhat M, Rollet-Kurhajec K, Bhat A, Farag A, Deschenes M, Wong P, Ghali P, Sebastiani G. Can J Gastro. 2017 Jan;2017:4381864.

Normothermic Ex Vivo Liver Perfusion Using Steen Solution as Perfusate for Human Liver Transplantation-First North American Results.

Selzner M, Goldaracena N, Echeverri J, Kaths JM, Linares I, Selzner N, Serrick C, Marquez M, Sapisochin G, Renner EL, Bhat M, McGilvray ID, Lilly L, Greig PD, Tsien C, Cattral MS, Ghanekar A, Grant DR. Liver Transpl. 2016 Nov 24;22(11):1501-1508.

The Implication of the Intestinal Microbiome in Complications of Cirrhosis.

Bhat M, Renner E, Bhat V, Arendt BM, Humar A, Allard JP. World Journal of Hepatology. 2016 Sep;8(27):1128-1136.

Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells.

Bhat M, Yanagiya A, Graber T, Razumilava N, Bronk S, Zammit D, Zhao Y, Zakaria C, Metrakos P, Pollak M, Sonenberg N, Gores G, Jaramillo M, Morita M, Alain T. Oncotarget. 2016 Jul 18;8(31):50542-50556.

Decreased PCSK9 expression in Hepatocellular Carcinoma.

Bhat M, Deschenes M, Marcus V, Skill N, Bouteaud J, Tan X, Negi S, Awan Z, Aikin R, Kwan J, Amre R, Tabaries S, Hassanain M, Maluccio M, Siegel P, Metrakos P. BMC Gastroenterology. 2015 Dec:2015 Dec 16;15:176.

Portal vein encasement predicts neoadjuvant therapy response in liver transplantation for perihilar cholangiocarcinoma protocol.

Bhat M, Hathcock M, Kremers WK, Darwish Murad S, Schmit G, Martenson J, Alberts S, Rosen CB, Gores GJ, Heimbach J. Transplant International. 2015 Dec:2015 Dec;28(12):1383. [Epub ahead of print].

Serum fibrosis biomarkers predict death and graft loss in liver transplant recipients: a 20-year study. Liver Transplantation.

Bhat M, Ghali P, Bhat A, Rollet K, Wong P, Deschenes M, Sebastiani G. 2015 Nov:2015 Nov;21(11):1383.

Prevalence and predictors of sleep disturbance among liver diseases in long-term transplant survivors.

Bhat M, Wyse J, Ghali P, Hilzenrat N, Wong P, Moodie E, Deschenes M. Can J Gastroenterol Hepatol. 2015 Nov:2015 Dec;29(8):44. [Epub ahead of print].

Comparison Costs of ERCP and MRCP in Patients with Suspected Biliary Obstruction Based on a Randomized Trial.

Adam V, Bhat M, Romagnuolo J, da Silveira E, Reinhold C, Valois E, Martel M, Barkun JS, Barkun AN. Value in Health. 2015 Sep:2015 Sep;18(6):767-7.

Systematic review: Preventive and therapeutic applications of metformin in liver disease

Bhat A, Sebastiani G, Bhat M. World J Hepatology. 2015 Jun 28;7(12):1652-9.

Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk?

Bhat M, Watt K. Clinical Transplantation. 2015 Jun 10:2015 Jul;29(7):654-6.

Targeting the translation machinery in cancer.

Bhat M, Robichaud N, Hulea L, Pelletier J, Sonenberg N, Topisirovic I. Nature Reviews Drug Discovery. 2015 Mar 6:2015 Apr;14(4):261-7.

P53 inducible gene 3 (PIG3): A Potential Marker for HCC beyond Milan criteria.

Bhat M, Goldstein S, Tchervenkov J, et al. J Gastro Hep Research. 2015;4(1):1434-1438.

Prevention and Management of Chronic Hepatitis B.

Bhat M, Ghali P, Deschenes M, Wong P. International Journal of Preventive Medicine. 2014 Dec;5(Suppl 3):S200-7.

Metformin does not improve Survival in patients with a new diagnosis of Hepatocellular Carcinoma.

Bhat M, Chaiteerakij R, Harmsen W, Therneau T, Gores G, Roberts L. World J Gastroenterol. 2014 Nov 14;20(42):15750-5.

Tumour Necrosis Factor-Alpha Polymorphism Increases the Risk for Nonvariceal Upper Gastrointestinal Bleeding in Patients Taking Proton Pump Inhibitors.

Bhat M, Lu Y, Marcil V, Amre D, Martel M, Seidman EG, Barkun A. Can J Gastroenterol Hepatol. 2014 Oct;28(9):488.

Care of the Liver Transplant Patient.

Bhat M, Al-Busafi S, Ghali P, Wong P, Deschenes M. Can J of Gastro. 2014 Apr;28(4):213-9.

A care coordination program to optimize management of cirrhosis: real life applicability and feasibility in the context of Canadian health care system.

Carpentier S, Bhat M, Deschenes M, Wong P, Ghali P, Sebastiani G. Can J of Gastro. 2014 Apr;28(4):221-2.

Randomised clinical trial: MRCP-first vs. ERCP-first approach in patients with suspected biliary obstruction due to bile duct stones.

Bhat M, Romagnuolo J, da Silveira E, Reinhold C, Valois E, Martel M, Barkun JS, Barkun AN. Aliment Pharmacol Ther. 2013 Nov;38(9):1045-53.

Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma.

Bhat M, Hassanain M, Simoneau E, Tzimas GN, Chaudhury P, Deschenes M, Valenti D, Ghali P, Wong P, Cabrera T, Barkun J, Tchervenkov JI, Metrakos P. Curr Oncol. 2013 Oct;20(5):265-72.

The Dissemination Of Consensus Recommendations On The Management Of Non Variceal Upper Gastrointestinal Bleeding: A National Cluster Randomized Trial.

Barkun AN, Bhat M, Armstrong D, Dawes M, Donner A, Enns R, Martin J, Moayyedi P, Romagnuolo J, Tugwell P. Canadian Medical Association Journal. 2013 Feb 19;185(3):E156-66.

The mTOR pathway in hepatic malignancies.

Bhat M, Nahum Sonenberg, Gores G. Hepatology. 2013;58(2):810-818.

eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.

Alain T, Morita M, Fonseca BD, Yanagiya A, Siddiqui N, Bhat M, Zammit D, Marcus V, Metrakos P, Voyer LA, Gandin V, Liu Y, Topisirovic I, Sonenberg N. Cancer Res. 2012 Oct 24;72(24):6468-76.

Smoking Increases Recurrent Viral Hepatitis After Liver Transplantation.

Bhat M, Deschenes M, Martel M, Wong P, Metrakos P, Ghali PM. Liver Transpl. 2012 Jul;18(7):828-33.

Prediction and prevention of upper gastrointestinal bleeding after cardiac surgery: a case control study.

Bhat M, Larocque M, Amorim M, Herba K, Martel M, De Varennes B, Barkun A. Can J Gastroenterol. 2012 Jun;26(6):340-4.

Hepatitis B in Infected Healthcare workers: Public Safety at what cost?

Bhat M, Ghali P, Deschenes M, Wong P. Can J Gastroenterol. 2012 May;26(5):257-60.

Immunosuppression With Budesonide for Liver Transplant Recipients With Severe Infections.

Bhat M, Ghali P, Marcus V, Michel RP, Wong P, Metrakos P, Deschenes M. Liver Transpl. 2012 Feb;18(2):262-3.

Antioxidant Therapy in Non-Alcoholic Steatohepatitis: a review of the evidence.

Al-Busafi S, Bhat M, Ghali P, Wong P, Deschenes M. Hepat Res Treat. 2012;2012:947575.

Secondary intestinal lymphangiectasia due to multiple myeloma.

Bhat M, Laneuville P, Marliss E, Costea F, Marcus V, Seidman E, Bitton A. Gastrointestinal Endoscopy. 2011 Sep 17;74(3):718-20.

Acute Obstructive Pancreatitis caused by Migrated Balloon Gastrostomy Tube.

Bhat M, Bridges E. CMAJ. 2011 Aug 9;183(11):E759.

Gastric Anisakiasis

Bhat M, Cleland P. Clinical Gastroenterology and Hepatology. 2010 Aug;8(8):A20.

Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository.

Bhat M, Nguyen GC, Pare P, Lahaie R, Deslandres C, Bernard EJ, Aumais G, Jobin G, Wild G, Cohen A, Langelier D, Brant S, Dassopoulos T, McGovern D, Torres E, Duerr R, Regueiro M, Silverberg MS, Steinhart H, Griffiths AM, Elkadri A, Cho J, Proctor D, Goyette P, Rioux J, Bitton A. Am J Gastroenterol. 2009 Sep 1;104(9):2233-40.

Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial.

Grizenko N, Bhat M, Schwartz G, Ter-Stepanian M, Joober R. J Psychiatry Neurosci. 2006 Jan 1;31(1):46-51.